| Filed On | Filing |
|---|---|
| 05 Oct 2026 |
Form 4: Ferrante Karen Jean, Director
Granted 759 Stock Option (Right to Buy) |
| 31 Aug 2026 |
Form 4: Morris Arlene, Director
Received 45,510 shares by exercise or conversion ($245K) · Sold 45,510 shares ($1.69M) |
| 06 Jul 2026 |
Form 4: Ferrante Karen Jean, Director
Granted 627 Stock Option (Right to Buy) |
| 11 Jun 2026 |
Form 4: Harwin Peter Evan, Director
Granted 17,901 Stock Option (Right to Buy) |
| 11 Jun 2026 |
Form 4: Ferrante Karen Jean, Director
Granted 17,901 Stock Option (Right to Buy) |
| 11 Jun 2026 |
Form 4: Cain Christopher W., Director
Granted 17,901 Stock Option (Right to Buy) |
| 11 Jun 2026 |
Form 4: Shegog Todd, Director
Granted 17,901 Stock Option (Right to Buy) |
| 11 Jun 2026 |
Form 4: Morris Arlene, Director
Granted 17,901 Stock Option (Right to Buy) |
| 11 Jun 2026 |
Form 4: Ros Matthew, Director
Granted 17,901 Stock Option (Right to Buy) |
| 21 May 2026 |
Form 4: Robbins Andrew R, Director
Gave 160,000 shares as a gift · Acquired 160,000 shares (Gift) |
| 03 Apr 2026 |
Form 4: Ferrante Karen Jean, Director
Granted 686 Stock Option (Right to Buy) |
| 31 Mar 2026 |
Form 4: Fairmount Funds Management Llc, Director
Received 7,000,000 shares by conversion · Sold 7,000,000 shares ($243M) |
| 22 Jan 2026 |
Form 4: Fairmount Funds Management Llc, Director
Sold 3,500,000 shares ($127M) |
| 05 Jan 2026 |
Form 4: Ferrante Karen Jean, Director
Granted 643 Stock Option (Right to Buy) |
| 30 Dec 2025 |
Form 4: Kearns Evan, Chief Legal Officer
Sold 65,000 shares ($2.52M) |
| 30 Dec 2025 |
Form 4: Green John L., Chief Financial Officer
Sold 77,000 shares ($2.98M) |
| 30 Dec 2025 |
Form 4: Sachs Jessica, Chief Medical Officer
Sold 82,642 shares ($3.2M) |
| 30 Dec 2025 |
Form 4: Robinson John Edward, Chief Scientific Officer
Sold 90,000 shares ($3.49M) |
| 19 Dec 2025 |
Form 4: Robinson John Edward, Chief Scientific Officer
Received 370,000 shares as a grant or award · Gave up 139,998 shares to cover exercise price or tax ($5.52M) · Granted 65,000 Stock Option (Right to Buy) |
| 19 Dec 2025 |
Form 4: Robbins Andrew R, Director
Received 1,025,000 shares as a grant or award · Gave up 367,497 shares to cover exercise price or tax ($14.5M) · Granted 245,000 Stock Option (Right to Buy) |
Loading...